LawSnap
Employment Law Health Care

ZipHealth survey: 47% of Gen Z prioritize GLP-1 drug coverage in job choices

Published
Source fastcompany.com open_in_new
Score
6

Why it matters

A March 2026 ZipHealth survey of 1,004 U.S. workers found 47% of Gen Z (vs. 35% millennials, 36% Gen X) say GLP-1 coverage (e.g., Ozempic, Wegovy) would sway them between similar job offers; 9% of Gen Z would accept a pay cut for it, and 54% overall would trade perks like a week of PTO.[3] Workers view it as a standard benefit (51%), though 58% of Gen Z avoid discussing weight goals with HR.[1][3]

Key players include ZipHealth (survey conductor), Eli Lilly (offering employer platforms for affordable access), FDA (approved Wegovy pill in Dec 2024), and surveys from KFF (1 in 8 adults using GLP-1s, Nov 2024), IFEBP (55% employers cover for diabetes only, 2025), and KFF Employer Health Benefits (19% large employers cover for weight loss in 2025, up among largest firms).[1][2][3] No specific legislation mandates coverage; employers have discretion, though state mandates apply to fully insured plans.[1]

GLP-1s, originally for diabetes, gained weight-loss traction post-2022 popularity; coverage rose from 26% (2024) to 34-36% for weight loss by 2025 amid high demand (18% adults used), but costs strain plans (66% largest employers report significant impact).[1][2][4][8] Gen Z's prior skepticism (Levity 2025) shifted with wellness trends.[3]

Newsworthy as of April 2026 for revealing Gen Z job negotiation shift amid rising employer coverage (e.g., 43% firms 5,000+ workers) and usage, signaling wellness benefits evolving beyond traditional perks like snacks or PTO.[1][2][3][7]

Sources

[1] https://www.fisherphillips.com/en/insights/insights/employer-faqs-on-the-rise-of-glp-1-drugs-for-weight-loss-and-the-workplace-impact
[2] https://www.healthsystemtracker.org/brief/perspectives-from-employers-on-the-costs-and-issues-associated-with-covering-glp-1-agonists-for-weight-loss/
[3] https://www.vice.com/en/article/gen-z-might-turn-down-your-job-offer-if-it-doesnt-come-with-ozempic/
[4] https://www.mahoneygroup.com/drug-coverage-weight-loss/
[5] https://www.tebra.com/theintake/healthcare-reports/weight-loss-medications-and-wellness-resolutions
[6] https://phti.org/wp-content/uploads/sites/3/2025/12/PHTI-Employer-Approaches-to-GLP-1-Coverage-Market-Trend-Report.pdf
[7] https://www.ypulse.com/newsfeed/2026/04/06/is-ozempic-becoming-part-of-gen-zs-job-negotiations/
[8] https://www.ebri.org/content/full/glp-1-coverage-and-its-impact-on-employment-based-health-plan-premiums--a-simulation-based-analysis
[9] https://talker.news/2026/01/08/survey-reveals-americans-embrace-glp-1-drugs-as-wellness-trend/
[10] https://www.bbrown.com/us/insight/state-of-glp-1-medication-coverage-for-weight-loss-employer-survey-results/
[11] https://www.mensfitness.com/news/gen-z-glp1-medications-for-weight-loss
[12] https://www.kff.org/health-costs/perspectives-from-employers-on-the-costs-and-issues-associated-with-covering-glp-1-agonists-for-weight-loss/
[13] https://www.statista.com/topics/50397/glp-1-drug-use-for-weight-loss-survey/
[14] https://www.managedhealthcareexecutive.com/view/faq-what-employers-and-employees-should-know-about-glp-1-coverage-costs-and-access
[15] https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/future-of-wellness-trends
mail

Get notified about new Employment Law developments

Primary sources. No fluff. Straight to your inbox.

Related

View all Employment Law

See more entries tagged Employment Law.